Title:
抗悪性腫瘍剤組成物
Document Type and Number:
Japanese Patent JP6402393
Kind Code:
B2
Abstract:
To provide a satisfactory anticancer agent composition suppressing the growth of cancer (malignant tumor) reliably and hardly causing side effects, the present invention is directed to an anticancer agent composition including the following agents as active ingredient; a LAT1 inhibitor, and one or more agents selected from the group consisting of an alkylating agent, a platinum-based antineoplastic agent, an anti-metabolite, a topoisomerase inhibitor, an anti-microtubule polymerizing agent, a hormonal agent, an anti-microtubule depolymerizing agent, an anticancer antibiotic, and a molecular targeted agent.
Inventors:
Hitoshi Endo
Wemp, Michael F
Peyron, Jean-Francois
Naohiko Anzai
Jutaba, Promsk
Wemp, Michael F
Peyron, Jean-Francois
Naohiko Anzai
Jutaba, Promsk
Application Number:
JP2014557910A
Publication Date:
October 10, 2018
Filing Date:
June 07, 2014
Export Citation:
Assignee:
J-Pharma Co., Ltd.
International Classes:
A61K31/416; A61K31/436; A61K31/513; A61K31/573; A61K31/69; A61K31/704; A61K33/243; A61K38/50; A61P35/00; A61P35/02
Foreign References:
| WO2008081537A1 |
Other References:
Cancer Letters,2009年,Vol.276,No.1,p95-101
Biochemical and Biophysical Research Communications,2013年,Vol.439,No.1,p103-108
Veterinary Journal,2013年,Vol.198,No.1,p164-169
Experimental Cell Research,2009年,Vol.315,No.3,p485-497
Cancer Science,2010年,Vol.101,No.1,p173-179
Biochimica et Biophysica Acta,2001年,Vol.1514,No.2,p291-302
Journal of Pharmacological Sciences,2014年 2月,Vol.124,No.2,p208-217
Drug Delivery System,2012年,Vol.27,No.5,p342-349
Oncotarget,2012年,Vol.3,No.8,p811-823
Journal of Clinical Investigation,2008年,Vol.118,No.9,p3038-3050
癌と化学療法,1994年,Vol.21,No.4,p517-523
New England Journal of Medicine,2013年,Vol.369,No.18,p1691-1703
Anticancer Research,2010年,Vol.30,No.11,p4619-4624
Biochemical and Biophysical Research Communications,2013年,Vol.439,No.1,p103-108
Veterinary Journal,2013年,Vol.198,No.1,p164-169
Experimental Cell Research,2009年,Vol.315,No.3,p485-497
Cancer Science,2010年,Vol.101,No.1,p173-179
Biochimica et Biophysica Acta,2001年,Vol.1514,No.2,p291-302
Journal of Pharmacological Sciences,2014年 2月,Vol.124,No.2,p208-217
Drug Delivery System,2012年,Vol.27,No.5,p342-349
Oncotarget,2012年,Vol.3,No.8,p811-823
Journal of Clinical Investigation,2008年,Vol.118,No.9,p3038-3050
癌と化学療法,1994年,Vol.21,No.4,p517-523
New England Journal of Medicine,2013年,Vol.369,No.18,p1691-1703
Anticancer Research,2010年,Vol.30,No.11,p4619-4624
Attorney, Agent or Firm:
Ito On